Get started
REGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALS

REGENERON PHARMACEUTICALS

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4REGN trade ideas

REGN- See How Important The Use Of Trend Channels Are? 10-30 For those interested in buying support, especially know considering how short term extended things are these days. Its all about the blue line. It also helps define ones entry risk here. If buying here you are buying 20 points away from a support zone (thanks anyway I say). Given this issue is tagging a trend channel resistance zone? That is all the more reason to let them come to you in the form of a pullback. After all to a chartist the adage of buy support and sell resistance is a classic mantra isn't it? Even more so when you have an issue that just tagged the trend channel resistance zone. Sure its pulling back but still needs more chart time. This chart is also a good example of how the trend channel keeps you away from going long at the wrong time and AFTER a run has been made already. The use of trend channels are your best friend. Not only do they help you manage the overall trend they keep you from getting emotional at key levels. At resistance? They keep you away from that dreaded fear of missing it AFTER you already missed it emotional trade. At support they keep you away from caving into fear and selling at a support zone. For informational and educational purposes only. These are not recommendations. Trade at your own risk.
NASDAQ:REGN
by Amazingpowerpatternguy
1
Regeneron Long-term Trend Remains Intact.Many sector leaders like Gilead, Celgene, and Biogen all had a nice run up at the end of the week, which is encouraging given people tend to sell on Friday, especially in this market. This bad boy went berserk in April 2013, flied away from this trend line and entered into a channel, which by the way, it broke exactly one year later, April 2014. Since then Regeneron had fallen back to this trend line, and it tested the high 270s support 3 times in the past month and successfully rebounded. I do believe the biotech selloff is over, however, a further selloff of other momo stocks(TWTR, TSLA, etc.)this week spoiled the party and botched this long anticipated revocery. But this doesn't mean the party is over, it just means it's postponed. Plus, a big plus, Sanofi bought god knows how many shares of REGN at 310 in March and now owns a big chunk(30% ?) of the company. If Sanofi thought 310$ a share was fair, what's holding us back from snapping up REGN 280$ a share? And given the current M&A frenzy, who knows right?
NASDAQ:REGNLong
by Jakeccc